Belgium
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 5.80 B
|
Dec. 31, 2023 | USD 195.15 | -0.39% |
|
Belgium |
|
2 |
USD 4.58 B
|
Dec. 31, 2023 | USD 19.13 | -0.63% |
|
Belgium |
|
3 |
USD 3.23 B
|
Dec. 31, 2023 | USD 19.81 | 0.71% |
|
Belgium |
|
4 |
USD 473.20 M
|
Dec. 31, 2023 | USD 13.71 | -0.44% |
|
Belgium |
|
5 |
USD 264.60 M
|
Dec. 31, 2023 | USD 24.20 | -0.41% |
|
Belgium |
|
6 |
USD 0.00
|
Dec. 31, 2023 | USD 3.28 | -5.91% |
|
Belgium |
|
7 |
USD 0.00
|
Dec. 31, 2023 | USD 150.68 | -0.48% |
|
Belgium |
The Biotechnology company in Belgium with the highest Revenue is UCB SA (Brussels Stock Exchange: UCB.BR) at USD 5.80 B.
The Biotechnology company in Belgium with the lowest Revenue is Financière de Tubize SA (Brussels Stock Exchange: TUB.BR) at USD 0.00.
The top 10 Biotechnology companies in Belgium by Revenue are UCB SA, Azelis Group NV, Tessenderlo Group NV, Ion Beam Applications SA, Galapagos NV, Biotalys NV and Financière de Tubize SA.
The bottom 10 Biotechnology companies in Belgium by Revenue are Financière de Tubize SA, Biotalys NV, Galapagos NV, Ion Beam Applications SA, Tessenderlo Group NV, Azelis Group NV and UCB SA.